Elizabeth Garrett-Mayer to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.709
-
The continual reassessment method for dose-finding studies: a tutorial. Clin Trials. 2006; 3(1):57-71.
Score: 0.251
-
A likelihood-based approach for computing the operating characteristics of the 3+3 phase I clinical trial design with extensions to other A+B designs. Clin Trials. 2015 Feb; 12(1):24-33.
Score: 0.116
-
Dose-finding clinical trial design for ordinal toxicity grades using the continuation ratio model: an extension of the continual reassessment method. Clin Trials. 2012 Jun; 9(3):303-13.
Score: 0.097
-
Proportional odds model for dose-finding clinical trial designs with ordinal toxicity grading. Stat Med. 2011 Jul 30; 30(17):2070-80.
Score: 0.090
-
Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee. Clin Cancer Res. 2010 Mar 15; 16(6):1726-36.
Score: 0.084
-
Risks and benefits associated with novel phase 1 oncology trial designs. Cancer. 2007 Sep 01; 110(5):1115-24.
Score: 0.071